Laboratory confirmed influenza (follow-up; assessed with: PCR or viral culture)
|
|
Randomized trials
| | | | | | | | | | ⊕ ⊕ ⊕ ⊕ HIGH |
CRITICAL
|
Influenza like illness (follow-up; assessed with)
|
|
Randomized trials
| | | | | | | | | | ⊕ ⊕ ⊕ ⊕ HIGH |
IMPORTANT
|
Hospitalization (follow-up; assessed with)
|
|
Randomized trials
| | | | | | | | | | ⊕ ⊕ ⊕ ⊕ HIGH |
CRITICAL
|
Medically attended respiratory illness (follow-up; assessed with)
|
|
Randomized trials
| | | | | | | | | | ⊕ ⊕ ⊕ ⊕ HIGH |
CRITICAL
|
Fever due to vaccination (follow-up mean, assessed with)
|
|
Randomized trials
| | | | | | | | | | ⊕ ⊕ ⊕ ⊕ HIGH |
IMPORTANT
|
Guillain-Barre syndrome (follow-up mean, assessed with)
|
|
Observational study
| | | | | | | | | | ⊕ ⊕ ΟΟ LOW |
IMPORTANT
|
Anaphylaxis (follow-up mean, assessed with)
|
|
Observational study
| | | | | | | | | | ⊕ ⊕ ΟΟ LOW |
CRITICAL
|